in 2013. Methamphetamine has a high dependence liability (Murray 1998; Wolkoff 1997) . In 2013, methamphetamine treatment accounted for the majority of treatment cases in many countries (UNODC 2015) .
Methamphetamine is a significant problem in East and South-East Asia ('Yaba'; 'Ice'; 'Shabu') (Kulsudjarit 2004) , North America ('Crystal Meth', 'Crank') and Australia ('Ice') (UNODC 2015) and more recently indicated as new trend in Europe with regard to increasing availability of crystalline methamphetamine in European countries such as Germany, Greece ('Sisa') and Turkey where use of methamphetamine has not been reported before (EMCDDA 2014a, b) . Methamphetamine has historically dominated the drug market in the Czech and Slovak Republics ('Pervitin', 'Vint', 'Shirka' (Csete 2012; Zábranský 2007) . With the exception of the Czech and Slovak Republic, a low prevalence of methamphetamine use was previously reported in most European member states (Bruggisser et al. 2010; Csemy et al. 2002; Griffiths et al. 2008; Krakowiak et al. 2010; Maxwell and Rutkowski 2008; McKetin et al. 2008; Schifano et al. 2010; Sudakin and Power 2009; Verschraagen et al. 2007) . Rising seizures are reported in the Baltics and Eastern Europe (Belarus, Latvia, Lithuania and the Republic of Moldova), and with diffusion of use to further afield in the Nordic countries, Germany, Cyprus, Greece and Portugal (Degenhardt et al. 2010; EMCDDA 2014a, b; Griffiths et al. 2008; Pietsch et al. 2013; UNODC 2015) .
EMCDDA reporting in recent times has underscored the unique cultural nature and national characteristics of methamphetamine use in comparison to other illicit drug use across Europe. Popularity and appetite for methamphetamine in the Czech Republic originated from user ingenuity once detached from imported drugs by the Iron Curtain (Kulish 2007) . However, regional trends in methamphetamine markets have been observed in the 2013 EMCDDA Trendspotter study, with distinct use patterns, production, and marketing of the drug (EMCDDA 2014a, b) . Factors stimulating the diffusion of methamphetamine from the Czech Republic into Europe whilst not significant and impeded by the presence of other stimulant drugs (cocaine, amphetamine and MDMA) (Griffiths et al. 2008) appear to centre on its appeal as alternative to cocaine, along with the migrant flow of Czech workers within the EU domain (Kulish 2007) . More recently, the supply diffusion of methamphetamine observed across Europe has indicated the potential replacement of amphetamine in the stimulant markets, from marginalised problematic drug user populations who smoke and inject, into that of socially integrated recreational users who sniff or inject, and the displacement of production itself (EMCDDA-Europol 2009 ). In the UK, methamphetamine use is appearing among high risk more affluent groups of drug users such as men who have sex with men, and engage in 'chemsex' activity (MSM) (Bourne et al. 2015; EMCDDA 2014a; . In Central and Eastern Europe, the tradition of home manufacture of 'Pervitin' is culturally and historically grounded (Griffiths et al. 2008; Grund and Merkinaite 2009; Mravčík et al. 2008; Van Hout 2014; Zábranský 2007) . Production in the Czech Republic generally takes place in 'kitchen labs' for own personal use (Zábranský 2007) . Small groups of 'cooks' and their helpers characterised by close personal relationships in home production and self supply dominate the system (Miovský 2007) . More recently, larger (mid to large scale) methamphetamine production sites were detected outside of the Czech Republic in the Slovac Republic, Belgium, Netherlands, Poland, Portugal, Ireland, United Kingdom and Germany (EMCDDA-Europol 2009). It can be easily produced from pre-cursor substances pseudoephedrine and ephedrine found as ingredients in common 'over the counter' cold remedies for symptomatic relief of colds, flu and other similar conditions (Topp et al. 2002) . According to EMCDDA-Europol (2009) five known methamphetamine production methods exist in Europe, with the three most common known as lithium-ammonia, hypophosphorous acid/iodine and hydriodic acid/red phosphorus. All three are dependent on availability of pre-cursors, the expertises of 'cooks' and are relatively simple, one-step reactions of ephedrine or pseudo-ephedrine in cold remedies sold without prescription in pharmacies, using stainless steel or glass equipment. The generation of hydrogen gas, toxic fumes, and corrosive and flammable hazards are evident (Europol 2007a, b, c) . Media reporting in 2015 highlights concern around the profitability of 'Pervitin' manufacture with increasing flow of medicines from Poland to the Czech Republic for home manufacture of methamphetamine, involvement of Vietnamese in the production cycle and trafficking into Germany (Bavaria and Saxony) (Prague Daily Monitor 2015) .
Despite the low prevalence of methamphetamine use previously reported in most European Member States, in 2016, media reporting of 'Pervitin' in Ireland, a country with very low prevalence of methamphetamine use, increased. In 2015, the Health Service Executive issued a number of alerts regarding pharmacovigilance in dealing with Eastern European customer requests for multiple packs of over the counter medicines containing pseudoephedrine (for example Sudafed ®), and often in large groups. The Irish Health Products Regulatory Authority had considered reducing the size of medicine packs in a bid to counter the manufacture of methamphetamine (Logan 2012) , and in 2015, the Pharmaceutical Society of Ireland (PSI) issued a warning to pharmacists in relation to sales of pseudoephedrinecontaining products. Harm reduction services indicated concerns around claims of methamphetamine sold by Nigerian gangs in Dublin, as found to contain synthetic psycho-active methylenedioxypyrovalerone (MDPV) and pyrrolidinopentiophenone (PVP) some of the newer novel psychoactive substances (NPS). We present here the first known single case study of migrated 'Pervitin' home manufacture (hereafter referred to as 'cooking') into Ireland.
Method
Ethical approval for the study was granted at Waterford Institute of Technology, Republic of Ireland in October 2015. The study aimed to explore migrancy and the cultural choices and decision making for Eastern European drug users resident in Ireland to use and make 'Pervitin'. We utilised the Privileged Access Interviewing approach which has been successfully utilised in accessing hard to reach populations, particularly PWID where outsides are viewed with mistrust and suspicion, and which achieves rich data retrieval in short timeframes (March et al. 2006; Taylor and Kearney 2005; Van Hout and Bingham 2012) . The case was recruited from a known existing network of Eastern European accessing harm reduction services in Ireland. Despite several attempts to recruit members from within the 'cooking' group in terms of the key actors, this was not successful due to the closed and hidden nature of the network itself. Hence we report here on the single case observations of the processes and use patterns of 'Pervitin' within a closed Eastern European network in Dublin, Ireland.
The single case was interviewed twice at two time points six months apart following informed consent, and described her observations and experiences in relation to a known group of Czech and Slovakian 'Pervitin' cookers and users in Dublin, Ireland. Interview themes centred on cultural preferences to bring 'Pervitin' to Ireland, migration of 'Pervitin' specific cooking and using practices into Ireland, dynamics, meanings and settings around 'cooking', interplay with 'outsiders' and the existing Irish street drug market, sourcing of precursor ingredients and clandestine home cooking practices, accidents and risks of exposure.
Interviews were conducted in English, the case's second language, were in depth and lasted 90 min on both occasions. She did not receive compensation. We asked the case to describe and reflect on her experiences with 'Pervitin', and observations of 'Pervitin' cooking over the course of a year. Memos and observational and analytical field notes were included in the analysis notes (Caelli 2001) . Narratives were analysed by delineating the data into units of meaning and clustering into emergent thematic patterns within the holistic context (Moustakas 1994). 'Outliers' were analysed by the team under conditions by which outliers could be interpreted (De Castro 2003) .
Results
Findings are illustrative of the use and production of 'Pervitin' in Ireland among Eastern European migrants. Three central descriptive themes emerged from the data, namely; 'Pervitin' use, Decisions to Use and Effects; Legality and Hazards; and 'Clandestine Manufacture.'
Pervitin Use, Decisions to Use and Effects 'Pervitin' pricing, dosing properties, and effects of 'Pervitin' use were described by the case. Route of administration was reported as being primarily inhalation by others or insufflation which was the preferred route by the case herself. Injecting use of 'Pervitin' was not reported.
BI snort it, always. Other people that I know they'd smoke it. That wouldn't be for me, I dunno I find the addiction is stronger there if you smoke it never mind injecting or anything like that, that's not me. Snorting, fine you can control.P otency of 'Pervitin' was said to be very strong and as a result dosing in small quantities was described by our case, and advocated within user networks of Czech and Slovak immigrants. Moderated controlled use appeared normalised within these networks.
BThe Piko is so strong so strong, you do literally, say you have a straw, the opening of a straw is what I do and that would get me through the day, easily. And the longer you don't take it, the longer it would work then when you go back on it.Ŝ he reported no compulsion to re-dose throughout the day if using as Bmama's little helperô r at night when socialising with friends.
BIf I do take more, it's because I want to, not because I feel the needB Mama's little helper, because it's just to get you through the day kind of a thing, you know.Ĉ ost was the only reported negative outcome of 'Pervitin' use. B€150 a gram. Quite expensive and you never know what you're getting.P oor quality of Illicit substances in Ireland such as cocaine was reported as a motive to purchase and consume home made 'Pervitin'.
BThe Irish stuff isn't good, like if somebody says 'oh I have this cocaine', for me I'd say 'no' because I know that the Piko ['Pervitin'] is always good9
Methamphetamine type effects such as euphoria, lack of sleep or appetite, energy, increased well-being and sociability were described. Chronic outcomes centred on weight loss.
BYou don't need to drink, you can drink if you want -you can drink alcohol like crazy but you're not getting drunk, and you are talking non-stop, and all of a sudden it's morning you know.Ŵ hile the case described herself as BI don't think I am a person who has tendencies to addiction^as she did refer to development of tolerance and withdrawals over time.
BWhen it's gone, I notice my behaviour changes a little bit. I don't feel that I am looking for more, but only by reading up on it then, it's like BJesus yeah I do get a little bit more short tempered^or a bit more aggressive.Ĉ landestine Manufacture
Cooking of 'Pervitin' by migrated groups of Czech and Slovak individuals in Ireland was described, and appeared central to their cultural networks in Ireland.
BLike it's not coming from, imported in another country, it's actually cooked in Ireland. I really thought it was coming from Czech Republic, but they are actually Czech and Slovakian living in Dublin'
This occurred in private homes with a 'cook' as experienced clandestine chemist, and with peer users assisting. Other factors implicating decisions to purchase and use home-made 'Pervitin' centred on presence of different 'cooks' using different processes and ingredients, and the wide variability of quality and consistency of effect.
BIt's like Breaking Bad style, like they have it in the kitchen and then they're cooking it up, so it can be hit and miss. You never know because it's different people cooking it.T he ingredients (for example over the counter cold medications containing pseudoephedrine) required to make 'Pervitin' in the home are purchased in pharmacies in Ireland, as reported by the case.
Bthey are definitely buying the ingredients in IrelandT he case reported intentions of the cooks and users of 'Pervitin' to filter into the Irish drugs market as market competitor of existing street stimulants.
Bthe guy whoever cooks it in Dublin, they are hoping to get into the Irish market because the Irish are so -once you have those people or the young twenty year old like, once you get them hooked, I could see dangers thereL egality and Hazards
The case described how she did not worry about the legal consequences of possessing 'Pervitin'. This perception of security was grounded in her storage of the drug in her fridge at home. Street use and street dealing was not referred to, and 'Pervitin' appeared to be somewhat normalised by virtue of its manufacture and use within the home.
BThe cops -no. I don't carry it around with me either it's in my fridge you know.T he case was aware of hazards in safe storage in relation to paediatric consumption and accidental overdose. Her primary fear was of social services deeming her dependent on drugs and unable to care for her child.
BI am a single mum it would worry me a bit if whoever would say to the social and they would come out here and have a look, That would be my worry as a mother, a fear, that's not really the law.'
Discussion
This study is one of the first efforts in the literature to address and examine the migration of 'Pervitin' use and production to Ireland. Since no data have been available in Ireland so far, the use of this method as a first approach was justifiable. The study yielded unique insight into migration of this culturally specific drug, 'Pervitin' and how continued cultural contexts for use and 'cooking' remain intact when residing in the host country. Whilst we recognise the confines of this approach (Baxter and Jack 2008; Yin 2003) , the exploration of this recent novel and culturally specific drug practice within eastern European cultural networks in Ireland is unique and merited. The study yielded rich and innovative insights into the migration of the culturally specific drug, 'Pervitin' with Czech citizens and how continued cultural contexts for use and manufacture remain intact when residing in the host country. The diffusion of methamphetamine in Europe, whilst culturally bound to the Czech and Slovak Republics, is to date impeded by the strong market of traditional stimulant drugs (cocaine, amphetamine, MDMA) (Griffiths et al. 2008 ) and NPS. Griffiths et al. (2008) however underscore the need to monitor the spread of methamphetamines popularity in Europe as influenced by drug market factors, 'leakage' from areas of high prevalence, travel of young Europeans into areas of high prevalence, and user perceptions around desirability and cost benefit when compared to other stimulants. Despite anecdotal reporting of NPS branded as methamphetamine sold on Irish streets, this form of drug use and production appeared insular and confined by cultural boundaries.
Potency and cost were both high, and appeared to further solidify the exclusivity of this drug within these close networks of Czech migrants. Similar to extant literature in their originating country, 'Pervitin' is prepared by small, close knit groups of users, in this instance not injecting drug users, and revolving around the 'cook' (Grund 2005; Miovský 2007; Van Hout 2014; ) . Home-made labs represent atypical risk environments (Rhodes 2009; Miovský et al. 2015) with synthesis taking place in primitive settings, with substandard equipment and ingredients ). Equally concerning are the risks of contamination, absence of correct protocols and purification methods, and highly toxic reactants (Alves et al. 2015; Caldicott et al. 2005; Grund et al. 2013; Martyny et al. 2007; Ning Chiu et al. 2011; ) . Hazards in production centre on the potential for life threatening injuries in places serving simultaneously as lab and home due to fires and explosions, and the exposure to toxic by-products of bystanders and children (Lineberry and Bostwick 2006) . If children are present, concerns are evident with regard to environmental hazards and paediatric consumption (Grant 2007; Mecham and Melini 2002) .
Acute effects reported were similar to those reported in the literature and centred on disinhibition, euphoria, decreased need for food and sleep, increased sociability, wellbeing and energy, and with a high probability of dependence (Sheridan et al. 2006) . Adverse health consequences centre on the emergent, acute, subacute, and chronic effects on cardiac, neurologic, pulmonary, dental, and other systems (Lineberry and Bostwick 2006) . Given the range of health related harms associated with problematic use and the potential progression toward injecting use and risk of blood borne virus transmission (Hepatitis C/ HIV), public health and harm reduction surveillance is warranted.
Conclusion
Given its unique cultural nature and national characteristics, continued migration of Eastern European citizens across Europe, diffusion of clandestine production of 'Pervitin' warrants continued surveillance. In Ireland, given the recent regulatory concerns, and harm reduction service reporting around this issue, continued research is warranted in order to inform appropriate service responses. Such service responses require culturally appropriate information and outreach services to Eastern European service users. Equally warranted is the specialised training of critical care staff in meth lab injuries (Santos et al. 2005) .
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